Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robin Shane Readnour Insider Profile
4 Followers
Robin Shane Readnour, Director at AN2 Therapeutics, Inc., holds 1.24M shares in AN2 Therapeutics, Inc. (Ticker: ANTX).
Robin Shane Readnour AN2 Therapeutics, Inc. (ANTX)Director
AN2 Therapeutics, Inc. (ANTX)
Director
Ranked #71,099 out of 100,285 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-14.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Robin Shane Readnour's holdings
Insider Roles
Director
Roles that Robin Shane Readnour holds in companies
Most Profitable Insider Trade
The most profitable trade made by Robin Shane Readnour
Robin Shane Readnour's Trading History
List of latest transactions for each holding click on a transaction to see Robin Shane Readnour's performance on stock
You May Also Like
Robin Shane Readnour insider profile FAQ
What is the percentage of profitable transactions made by Robin Shane Readnour?
The percentage of profitable transactions made by Robin Shane Readnour is 25%.
What is the average return per transaction made by Robin Shane Readnour?
The average return per transaction made by Robin Shane Readnour is -14.70%.
What stocks does Robin Shane Readnour hold?
Robin Shane Readnour holds: ANTX stocks.
What was Robin Shane Readnour’s latest transaction?
Robin Shane Readnour latest transaction was an Uninformative Buy of ―.
What was Robin Shane Readnour's most profitable transaction?
Robin Shane Readnour’s most profitable transaction was an Informative Buy of ANTX stock on November 21, 2024. The return on the trade was 1.60%.
What is Robin Shane Readnour's role in AN2 Therapeutics, Inc.?
Robin Shane Readnour's role in AN2 Therapeutics, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.